Harvard ScientistsDevelop New Cell Therapy to Kill,  Prevent Brain  Cancer

Banner With Dots

The researchers took  advantage of living tumour cells' unique ability to  travel long distances  across the brain to return  to the site of their fellow  tumour cells.

Banner With Dots
Off-white Section Separator

Khalid Shah, a scientist from the lab of Harvard-affiliated  Brigham and Women’s Hospital, BWH led the research work.

Off-white Section Separator

A sophisticated mouse model of the lethal brain disease glioblastoma was used by the researcher to test its dual action, cancer-killing vaccination,  with encouraging  findings.

Off-white Section Separator

Using gene engineering, scientists are repurposing cancer cells to develop a therapeutic that kills tumor cells and stimulates the immune system to destroy primary tumors and prevent cancer.

Off-white Section Separator

The team developed a new cell therapy approach to eliminate established tumors and induce long-term immunity, training the immune system so that it can  prevent cancer from recurring.

Our goal is to take an  innovative but translatable approach so that we can develop a  therapeutic, cancer-killing vaccine that  ultimately will have a  lasting impact in  medicine

Khalid Shah